Contact
Lijo John
Title:Researcher, Dr. rer. nat./PhD
Research area :Virus-host-interactions, mRNA-vaccine, antivirals
Our current projects are focused on haploid genetic screens for generating information on host factors that are crucial for viruses such as Bluetongue, SARS-CoV-2 and Marburg virus. I am also involved in the Crimean Congo Haemorrhagic fever virus (CCHFV) vaccine project for developing RNA vaccine against CCHFV.
Current projects
All projects
For further projects, search here:
Publications
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection (2021)
Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46 (2021)
Human AdV-20-42-42, a promising novel adenoviral vector for gene therapy and vaccine product development (2021)
Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56 (2018)
Induction of stress granules by interferon and down-regulation by the cellular RNA adenosine deaminase ADAR1 (2014)
Hepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteins (2011)
Chikungunya virus capsid protein contains nuclear import and export signals (2013)
Converging evidence of mitochondrial dysfunction in a yeast model of homocysteine metabolism imbalance (2011)
Homocysteine- and cysteine-mediated growth defect is not associated with induction of oxidative stress response genes in yeast (2006)
Cigarette smoke extract induces changes in growth and gene expression of Saccharomyces cerevisiae (2005)